Published on : Apr 14, 2015
As per the recently published statistical analysis for the year 2013 by the HSE’s, the amount that is received by three Irish subsidiaries of UDG’s have summed up to around €112.4 million in the year 2013. The payments to the UDG firms which were formerly the United Drug make up around 25% of the total amount of €442.2 million which is paid out by the HSE to pharmaceutical firms in 2013 in accordance with the ‘hi-tech wholesale and manufacturer payments’.
The numbers states that United Drug Wholesale in Dublin received about €54 million with United Drug plc Limerick receiving €33.63m and United Drug plc Ballina netting €24.7 million for fees. The €442 million which is paid by the HSE determines around 15% increase on the €385 million given out to pharmaceutical firms under the scheme in the last year.
The figures also prove that the highest amount the HSE paid to one individual entity was €89 million, which was given to Abbvie Ltd, a company based in Abbott. It was founded in the month of January in 2013, with a specific goal to market the ground-breaking science to solve the biggest health troubles that are faced by the world.
Pfizer Ltd made an announcement recently that it was thinking over their decision to shut down its manufacturing unit based in Little Island, Cork, took care of around 160 jobs at the unit. It received around €57 million in 2013. Movianto informs that it is involved in implementing and developing streamlined logistics and distribution facilities on local, regional, and European level, who received about €44.4 million in payments in the year 2013. Some other firms that are included in the list are Vertex Pharmaceuticals. They received around €16 million and Cahill May Roberts who got around €14.15 million.